© All rights reserved to Barnea Jaffa Lande Law offices

Together is empowering

Search by Practice

Insights & News /  IPOs and Public Offerings

August 6, 2023

Stock Market Skeletons: How to Properly Execute a Merger

Hagit Ross, a partner in our firm’s Capital Markets Department, was interviewed by TheMarker on the phenomenon of companies going public via mergers with stock market skeletons.

June 14, 2021

IPO Wave Continues to Flourish – How Should Companies Prepare for an IPO?

The growing wave of IPOs on the Tel Aviv Stock Exchange is pushing an overwhelming number of private companies to consider going public.  Zvi Gabbay, head of the firm's Capital Markets Department and a former head of enforcement at the Israel Securities Authorities, was interviewed by the TheMarker for an article on the trend. Zvi explained how companies considering an IPO must behave vis-a-vis the public and the regulatory authorities in order to succeed.

December 25, 2019

Micky Barnea Op-Ed: TASE IPO – The Light at the End of the Tunnel?

Globes published an op-ed by Micky Barnea on the Tel Aviv Stock Exchange's latest move to attract new investors with a public offering of its shares. According to Micky, "This listing could be a turning point in anticipation of a long-awaited change, bringing a revival of the stock exchange and the domestic capital market."

May 13, 2018

Check-Cap Ltd. Completes Public Offering on NASDAQ

Barnea represented the US underwriter H.C. Wainwright Co., LLC in the public offering transaction issued by Check-Cap Ltd. via a prospectus on NASDAQ. Check-Cap Ltd. raised $20.2 million in gross proceeds, including in the exercise of an overallotment option, in shares and warrants. Check-Cap Ltd., an Israeli clinical-stage medical diagnostics company, is developing C-Scan®, a capsule-based system for preparation-free colorectal cancer screening.

April 26, 2018

Seminar on How TASE Can Spur Growth of Kibbutz Industry

Barnea, BDO Israel, and the Tel Aviv Stock Exchange (TASE) are hosting today a seminar on the accounting and legal aspects of issuing collective companies on the TASE.

April 22, 2018

Kibbutz-Owned Companies Prefer the Investment of Private Funds

Micky Barnea, our Managing Partner, was interviewed by Globes on kibbutz-owned companies' transition from launching IPOs on the stock exchange to seeking investments from private equity funds.

December 26, 2017

Micky Barnea Interviewed by Globes on Israel's Capital Market

Adv. Micky Barnea, our firm's managing partner, was interviewed by Globes on the major events that have taken place in Israel's capital market in the past year: the re-emergence of initial public offerings on the Tel Aviv Stock Exchange, the Bezeq affair, and ICOs.

December 13, 2017

Israel Securities Authority Blows Up the Bitcoin Bubble

Dr. Zvi Gabbay, head of our firm's Capital Markets Department, gave several media interviews (in Heb) following the Israel Securities Authority Chairman's remarks that companies whose values are based on bitcoin will not be included in the Tel Aviv Stock Exchange's (TASE) indices until a suitable regulatory framework is established. Zvi noted it is important to distinguish between the inclusion of companies engaged in trading and investing in virtual currencies on TASE's indices and the possibility that such companies will actually be traded on TASE.

November 13, 2017

Seminar with the Tel Aviv Stock Exchange and the Israel Builders Association

Barnea is hosting today with the Tel Aviv Stock Exchange and the Israel Builders Association a seminar for real estate and infrastructure companies exploring a potential IPO. Dr. Zvi Gabbay, Head of the Capital Markets Department, will discuss IPO from the eyes of a regulator.

April 4, 2017

The Hong Kong Stock Exchange has formally approved Israel as an ‘Acceptable Jurisdiction’.

Dr. Zvi Gabbay, Head of the Capital Markets Department at Barnea was interviewed by The Marker following the approval of the Hong Kong Stock Exchange (‘HKSE’) Israel as an ‘Acceptable Jurisdiction’. Zvi commented that the HKSE’s approval is currently limited to foreign listed Israeli public companies and Israeli private companies seeking a listing on the HKSE and it could also translate into cost savings for such companies.

March 27, 2017

Medigus Ltd. Completed a Nasdaq IPO

Barnea represented a group of US underwriters, led by H.C. Wainwright , LLC, in the process of submission of Medigus Ltd. of a prospectus for the Nasdaq listing. Medigus raised USD 7.5 million and will be traded on Nasdaq in parallel with its listing on the Tel Aviv Stock Exchange. Medigus Ltd is an Israel-based company active in the medical sector. It specializes in developing endoscopic procedures and devices.

September 30, 2016

Barnea & Co. Represented the Private Equity Fund IGP Investment in Jacada

Barnea represented Israel Growth Partners (IGP)  in an agreement to buy 300,000 Jacada shares, 7% of the company's share capital, from Robert (Bob) Ashton's investment firm Kinetic Catalyst Partners.

October 13, 2016

Australian stock exchange to Israeli tech firms: Come list Down Under

Dr. Zvi Gabbay, Partner and Head of the Capital Markets Financial Regulation Department at Barnea was interviewed by the Times of Israel regarding the growing interest of Israeli companies to list on the Australian Stock Exchange (ASX). Zvi commented that the Australian financial laws have earned a reputation as a creative and advanced regulatory regime that strikes a good balance between investor protection and a pro-business approach that understands the risk of over-regulation.

August 1, 2016

Cellect Biotechnology Completed a Nasdaq IPO

On 31st July 2016 Cellect Biotechnology announced that it has completed its Nasdaq IPO, raising $8.4 million. Cellect Biotechnology will be traded on Nasdaq in parallel with its listing on the Tel Aviv Stock Exchange. Barnea represented a group of US underwriters, led by H.C. Wainwright , LLC, in the process of submission by Cellect Biotechnology of a prospectus for the Nasdaq listing. Cellect Biotechnology develops innovative technologies in the stem cells sphere.
Enter your email for newsletter sign up: